407 related articles for article (PubMed ID: 12050268)
1. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa.
Grinspoon S; Thomas L; Miller K; Herzog D; Klibanski A
J Clin Endocrinol Metab; 2002 Jun; 87(6):2883-91. PubMed ID: 12050268
[TBL] [Abstract][Full Text] [Related]
2. Effects of estrogen and recombinant human insulin-like growth factor-I on ghrelin secretion in severe undernutrition.
Grinspoon S; Miller KK; Herzog DB; Grieco KA; Klibanski A
J Clin Endocrinol Metab; 2004 Aug; 89(8):3988-93. PubMed ID: 15292338
[TBL] [Abstract][Full Text] [Related]
3. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study.
Grinspoon S; Miller K; Herzog D; Clemmons D; Klibanski A
J Clin Endocrinol Metab; 2003 Mar; 88(3):1142-9. PubMed ID: 12629097
[TBL] [Abstract][Full Text] [Related]
5. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.
Boonen S; Rosen C; Bouillon R; Sommer A; McKay M; Rosen D; Adams S; Broos P; Lenaerts J; Raus J; Vanderschueren D; Geusens P
J Clin Endocrinol Metab; 2002 Apr; 87(4):1593-9. PubMed ID: 11932288
[TBL] [Abstract][Full Text] [Related]
6. Effect of Transdermal Estradiol and Insulin-like Growth Factor-1 on Bone Endpoints of Young Women With Anorexia Nervosa.
Singhal V; Bose A; Slattery M; Haines MS; Goldstein MA; Gupta N; Brigham KS; Ebrahimi S; Javaras KN; Bouxsein ML; Eddy KT; Miller KK; Schoenfeld D; Klibanski A; Misra M
J Clin Endocrinol Metab; 2021 Jun; 106(7):2021-2035. PubMed ID: 33693703
[TBL] [Abstract][Full Text] [Related]
7. Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo-Controlled Trial.
Haines MS; Kimball A; Meenaghan E; Bachmann KN; Santoso K; Eddy KT; Singhal V; Ebrahimi S; Dechant E; Weigel T; Ciotti L; Keane RJ; Gleysteen S; Mickley D; Bredella MA; Tan CO; Gupta R; Misra M; Schoenfeld D; Klibanski A; Miller KK
J Bone Miner Res; 2021 Nov; 36(11):2116-2126. PubMed ID: 34355814
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial.
Gordon CM; Grace E; Emans SJ; Feldman HA; Goodman E; Becker KA; Rosen CJ; Gundberg CM; LeBoff MS
J Clin Endocrinol Metab; 2002 Nov; 87(11):4935-41. PubMed ID: 12414853
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa.
Audí L; Vargas DM; Gussinyé M; Yeste D; Martí G; Carrascosa A
Pediatr Res; 2002 Apr; 51(4):497-504. PubMed ID: 11919336
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
[TBL] [Abstract][Full Text] [Related]
11. Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion.
Woods KA; Camacho-Hübner C; Bergman RN; Barter D; Clark AJ; Savage MO
J Clin Endocrinol Metab; 2000 Apr; 85(4):1407-11. PubMed ID: 10770174
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
Mauras N; Doi SQ; Shapiro JR
J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
[TBL] [Abstract][Full Text] [Related]
13. Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa.
Misra M; McGrane J; Miller KK; Goldstein MA; Ebrahimi S; Weigel T; Klibanski A
Bone; 2009 Sep; 45(3):493-8. PubMed ID: 19523548
[TBL] [Abstract][Full Text] [Related]
14. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.
Guevara-Aguirre J; Rosenbloom AL; Vasconez O; Martinez V; Gargosky SE; Allen L; Rosenfeld RG
J Clin Endocrinol Metab; 1997 Feb; 82(2):629-33. PubMed ID: 9024266
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise.
Seeman E; Szmukler GI; Formica C; Tsalamandris C; Mestrovic R
J Bone Miner Res; 1992 Dec; 7(12):1467-74. PubMed ID: 1481732
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.
Heiner JS; Greendale GA; Kawakami AK; Lapolt PS; Fisher M; Young D; Judd HL
J Clin Endocrinol Metab; 1995 Dec; 80(12):3412-8. PubMed ID: 8530574
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
[TBL] [Abstract][Full Text] [Related]
19. Effects of rhIGF-I administration on bone turnover during short-term fasting.
Grinspoon SK; Baum HB; Peterson S; Klibanski A
J Clin Invest; 1995 Aug; 96(2):900-6. PubMed ID: 7543494
[TBL] [Abstract][Full Text] [Related]
20. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
